ALLO
Price
$3.00
Change
-$0.01 (-0.33%)
Updated
Nov 5, 04:50 PM (EDT)
2 days until earnings call
APGE
Price
$58.24
Change
+$1.94 (+3.45%)
Updated
Nov 5, 04:52 PM (EDT)
6 days until earnings call
Ad is loading...

ALLO vs APGE

Header iconALLO vs APGE Comparison
Open Charts ALLO vs APGEBanner chart's image
Allogene Therapeutics
Price$3.00
Change-$0.01 (-0.33%)
Volume$7.59K
CapitalizationN/A
Apogee Therapeutics
Price$58.24
Change+$1.94 (+3.45%)
Volume$345
CapitalizationN/A
View a ticker or compare two or three
ALLO vs APGE Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLO vs. APGE commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and APGE is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ALLO: $3.00 vs. APGE: $56.30)
Brand notoriety: ALLO and APGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 162% vs. APGE: 71%
Market capitalization -- ALLO: $568.78M vs. APGE: $3.19B
ALLO [@Biotechnology] is valued at $568.78M. APGE’s [@Biotechnology] market capitalization is $3.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileAPGE’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • APGE’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 7 TA indicator(s) are bullish while APGE’s TA Score has 6 bullish TA indicator(s).

  • ALLO’s TA Score: 7 bullish, 2 bearish.
  • APGE’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than APGE.

Price Growth

ALLO (@Biotechnology) experienced а +11.94% price change this week, while APGE (@Biotechnology) price change was +2.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

APGE is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($3.19B) has a higher market cap than ALLO($569M). APGE YTD gains are higher at: 101.503 vs. ALLO (-6.542). APGE has higher annual earnings (EBITDA): -134.74M vs. ALLO (-256.56M). APGE has more cash in the bank: 676M vs. ALLO (445M). APGE has less debt than ALLO: APGE (4.08M) vs ALLO (87M). ALLO has higher revenues than APGE: ALLO (65K) vs APGE (0).
ALLOAPGEALLO / APGE
Capitalization569M3.19B18%
EBITDA-256.56M-134.74M190%
Gain YTD-6.542101.503-6%
P/E RatioN/AN/A-
Revenue65K0-
Total Cash445M676M66%
Total Debt87M4.08M2,131%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOAPGE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHLX9.730.01
+0.10%
Nationwide Bailard Intl Eqs M
KSMVX9.93N/A
N/A
Keeley Small-Mid Cap Value A
WASCX20.38-0.01
-0.05%
Delaware Ivy Asset Strategy Fund Cl C
FCIHX16.94-0.01
-0.06%
NYLI PineStone International Equity Cl P
MFRFX62.30-0.08
-0.13%
MFS Research A

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+10.29%
NTLA - ALLO
57%
Loosely correlated
+2.30%
FATE - ALLO
56%
Loosely correlated
+13.58%
CRSP - ALLO
55%
Loosely correlated
-0.28%
BEAM - ALLO
54%
Loosely correlated
+6.24%
PRME - ALLO
53%
Loosely correlated
-1.49%
More

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+3.32%
SYRE - APGE
39%
Loosely correlated
+3.27%
BHVN - APGE
38%
Loosely correlated
-1.65%
ALLO - APGE
38%
Loosely correlated
+10.29%
ACLX - APGE
37%
Loosely correlated
+0.31%
SRRK - APGE
34%
Loosely correlated
-2.64%
More